Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | 1.11% | 246.53 | 1.3% | $804.75m | |
| IMMU | Immunomedics, Inc. | 0.12% | 85.46 | 11.0% | $698.00m | |
| MRNA | Moderna, Inc. | 1.32% | 70.39 | 0.0% | $675.31m | |
| NVAX | Novavax, Inc. | -3.72% | 109.34 | 96.5% | $605.63m | |
| ILMN | Illumina, Inc. | 0.91% | 302.62 | 3.5% | $588.10m | |
| GILD | Gilead Sciences, Inc. | 0.98% | 62.86 | 1.0% | $579.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.86% | 563.40 | 2.7% | $435.15m | |
| BIIB | Biogen, Inc. | 4.08% | 284.44 | 1.6% | $348.65m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.71% | 266.28 | 1.9% | $338.44m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.98% | 113.31 | 2.0% | $282.42m | |
| EXAS | EXACT Sciences Corp. | 2.02% | 99.67 | 20.7% | $262.48m | |
| SRNE | Sorrento Therapeutics, Inc. | 5.97% | 10.21 | 1.5% | $255.24m | |
| SGEN | Seattle Genetics, Inc. | 2.18% | 188.98 | 6.0% | $216.76m | |
| VXRT | Vaxart, Inc. | -6.35% | 6.93 | 0.0% | $200.30m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.08% | 52.44 | 3.0% | $193.73m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.